US 11,851,419 B2
GLP-1R modulating compounds
Gediminas J. Brizgys, San Carlos, CA (US); James S. Cassidy, San Francisco, CA (US); Chienhung Chou, Dublin, CA (US); Jeromy J. Cottell, Redwood City, CA (US); Chao-I Hung, San Mateo, CA (US); Kavoos Kolahdouzan, San Francisco, CA (US); James G. Taylor, Burlingame, CA (US); Nathan E. Wright, San Diego, CA (US); and Zheng-Yu Yang, Palo Alto, CA (US)
Assigned to Gilead Sciences, Inc., Foster City, CA (US)
Filed by Gilead Sciences, Inc., Foster City, CA (US)
Filed on Nov. 18, 2021, as Appl. No. 17/530,300.
Claims priority of provisional application 63/134,505, filed on Jan. 6, 2021.
Claims priority of provisional application 63/116,630, filed on Nov. 20, 2020.
Prior Publication US 2022/0177449 A1, Jun. 9, 2022
Int. Cl. C07D 401/14 (2006.01); A61K 45/06 (2006.01); C07D 405/14 (2006.01)
CPC C07D 401/14 (2013.01) [A61K 45/06 (2013.01); C07D 405/14 (2013.01)] 4 Claims
 
1. A compound, or a pharmaceutically acceptable salt thereof, wherein the compound has the structure:

OG Complex Work Unit Chemistry

OG Complex Work Unit Chemistry

OG Complex Work Unit Chemistry

OG Complex Work Unit Chemistry